1-hydroxy-3-amino-2-pyrrolidone has been researched along with Basal Ganglia Diseases in 1 studies
1-hydroxy-3-amino-2-pyrrolidone: a CNS depressant; structure in first source
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Tremors induced by chemical agents (nicotine, zinc and tremorine) were markedly inhibited by HA-966." | 3.65 | 1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases. ( Bonta, IL; De Vos, CJ; Grijsen, H; Hillen, FC; Noach, EL; Sim, AW, 1971) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonta, IL | 1 |
| De Vos, CJ | 1 |
| Grijsen, H | 1 |
| Hillen, FC | 1 |
| Noach, EL | 1 |
| Sim, AW | 1 |
1 other study available for 1-hydroxy-3-amino-2-pyrrolidone and Basal Ganglia Diseases
| Article | Year |
|---|---|
1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases.
Topics: Acoustic Stimulation; Amines; Amphetamine; Animals; Basal Ganglia Diseases; Behavior, Animal; Brain | 1971 |